QuickView for leukemia inhibitory factor receptor binding (biogroup)

1. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
2. Glioblastoma U-87 MG cells expressing KLF4 wildtype or R458A mutation induced with doxycycline
3. L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
4. Renal cell carcinomas - Clear cell, papillary, chromophobe, and oncocytoma
5. L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens

There were no matches for leukemia inhibitory factor receptor binding

1. Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
2. Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could b…
3. Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloi…
4. Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixi…
5. Study of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (A…